Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,803 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03458221 | Signal TrAnsduction Pathway Activity Analysis in OVarian cancER(STAPOVER) | recruiting | Phase 2 / Phase 3 | 148 | Gynaecologisch Oncologisch Centrum ZuidOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05019846 | SRT Versus SRT+ADT in Prostate Cancer(SPA) | recruiting | Phase 3 | 310 | Marco Lorenzo BonuOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04861415 | SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer(SHARP) | recruiting | N/A | 55 | Dr. Gerard MortonOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05808933 | Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer(MARF-ESC) | recruiting | — | 150 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05810701 | FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer(FRAGINOC) | recruiting | N/A | 300 | Odense University HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04409860 | The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer(CQGOG0102) | recruiting | N/A | 120 | Chongqing University Cancer HospitalOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT05799469 | Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 36 | Chongqing University Cancer HospitalOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT04138914 | Phase II Trial of Focal Cryotherapy for Prostate Cancer | active not recruiting | N/A | 30 | Singapore General HospitalOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT05034991 | The Role of Endometrial Blood Flow in Endometrial Cancer | recruiting | — | 75 | Far Eastern Memorial HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05054296 | Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring | recruiting | Phase 2 | 200 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05255471 | MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.(MITO 35B) | recruiting | Phase 3 | 200 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05778097 | Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)(ARES) | not yet recruiting | Phase 2 | 103 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 21, 2023 | clinicaltrials |
| NCT05733000 | CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors | recruiting | Phase 2 | 94 | Northwestern UniversityOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT05753566 | Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | recruiting | Phase 2 | 96 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05670938 | Follow-up After Surgery for Testicular Cancer(FUTURE-testis) | recruiting | — | 145 | Erasmus Medical CenterOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05672485 | 99mTc-P137 SPECT/CT in Prostate Cancer | recruiting | N/A | 40 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05733806 | Study on Gynecological Rare Cancers(MITO9B) | recruiting | — | 500 | National Cancer Institute, NaplesOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT04999696 | Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical Cancer(MITOR) | not yet recruiting | N/A | 820 | Chang Gung Memorial HospitalOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05722392 | Safety and Efficacy of Two-step Radical Prostatectomy | recruiting | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT00430183 | Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer | active not recruiting | Phase 3 | 788 | Alliance for Clinical Trials in OncologyOTHER | 2 | Feb 9, 2023 | clinicaltrials |
| NCT03836196 | Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease(OPTiMAL) | recruiting | N/A | 105 | British Columbia Cancer AgencyOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT05717582 | Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment(CHAMPION) | not yet recruiting | Phase 2 | 47 | Fudan UniversityOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04625556 | Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05210270 | HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy(HYACINCT) | not yet recruiting | Phase 1 / Phase 2 | 55 | University of Santo Tomas Hospital, PhilippinesOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT02381990 | MRI/Ultrasound Fusion Guided Prostate Cryotherapy(FIPC) | recruiting | — | 5,000 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05241236 | MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer(MRFLA) | recruiting | — | 5,000 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05698576 | TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer(TPF-LITT) | recruiting | N/A | 20 | Urological Research Network, LLCOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05696002 | Advanced Pelvic Surgical Oncology Database - Prospective Observational Study | recruiting | — | 300 | Glasgow Royal InfirmaryOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT03621904 | PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer(PROMOTE) | recruiting | — | 150 | Radboud University Medical CenterOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT05681416 | Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer(ProFam-Risk) | not yet recruiting | N/A | 300 | Heinrich-Heine University, DuesseldorfOTHER | 0 | Jan 12, 2023 | clinicaltrials |
| NCT02803086 | Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer(IHU-WPRT-TOX) | active not recruiting | — | 700 | IRCCS San RaffaeleOTHER | 1 | Jan 6, 2023 | clinicaltrials |
| NCT05524389 | Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions | not yet recruiting | Phase 3 | 624 | Peking Union Medical College HospitalOTHER | 0 | Nov 23, 2022 | clinicaltrials |
| NCT00860652 | Radiotherapy - Adjuvant Versus Early Salvage(RAVES) | active not recruiting | N/A | 333 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Nov 18, 2022 | clinicaltrials |
| NCT05614700 | Prostate Reirradiation Toxicity Outcomes Feasibility Study(RO-PIP) | not yet recruiting | N/A | 60 | University of LeedsOTHER | 0 | Nov 15, 2022 | clinicaltrials |
| NCT02044172 | Prostate Testing for Cancer and Treatment(ProtecT) | active not recruiting | N/A | 82,849 | University of OxfordOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05373316 | Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy(AFFIRM) | not yet recruiting | Phase 2 | 95 | Radboud University Medical CenterOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05607329 | Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial | recruiting | N/A | 400 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05597852 | Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer(FIRST STAR) | recruiting | N/A | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT04161664 | Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy(CRAVAT) | recruiting | Phase 2 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT03061539 | Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature | active not recruiting | Phase 2 | 380 | University College, LondonOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05550558 | Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer(CAN-RESPOND) | not yet recruiting | Phase 2 | 43 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Sep 28, 2022 | clinicaltrials |
| NCT05557604 | Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer(STUNNIN) | recruiting | Phase 2 | 146 | Regina Elena Cancer InstituteOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05551208 | Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi | recruiting | Phase 2 | 42 | Chongqing University Cancer HospitalOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT05510830 | Diagnostic Cervical Conization for Persistent Infection or Integration of HPV | not yet recruiting | N/A | 250 | Tongji HospitalOTHER | 1 | Sep 8, 2022 | clinicaltrials |
| NCT05528237 | HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals(ACCESS) | enrolling by invitation | N/A | 50 | University of WashingtonOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT05030805 | Transcriptional Map of Ovarian Cancer at the Single Cell Level(Ova-seq) | recruiting | — | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT04403867 | The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.(ITCMicroUtCa) | recruiting | — | 500 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05406999 | Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer | recruiting | Phase 2 | 900 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT03789253 | Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer | recruiting | — | 300 | National Taiwan University HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT05500118 | Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU | recruiting | — | 120 | Shenzhen Maternity & Child Healthcare HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Apr 18, 2023source: clinicaltrials